Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia.

Mezzatesta C, Bornhauser BC.

Front Cell Dev Biol. 2019 Mar 19;7:40. doi: 10.3389/fcell.2019.00040. eCollection 2019. Review.

2.

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways.

Magistroni V, Mauri M, D'Aliberti D, Mezzatesta C, Crespiatico I, Nava M, Fontana D, Sharma N, Parker W, Schreiber A, Yeung D, Pirola A, Readelli S, Massimino L, Wang P, Khandelwal P, Citterio S, Viltadi M, Bombelli S, Rigolio R, Perego R, Boultwood J, Morotti A, Saglio G, Kim DW, Branford S, Gambacorti-Passerini C, Piazza R.

Haematologica. 2019 Sep;104(9):1789-1797. doi: 10.3324/haematol.2017.179937. Epub 2019 Feb 28.

3.

SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub.

Piazza R, Magistroni V, Redaelli S, Mauri M, Massimino L, Sessa A, Peronaci M, Lalowski M, Soliymani R, Mezzatesta C, Pirola A, Banfi F, Rubio A, Rea D, Stagno F, Usala E, Martino B, Campiotti L, Merli M, Passamonti F, Onida F, Morotti A, Pavesi F, Bregni M, Broccoli V, Baumann M, Gambacorti-Passerini C.

Nat Commun. 2018 Jun 6;9(1):2192. doi: 10.1038/s41467-018-04462-8.

4.

RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients.

Piazza R, Cecchetti C, Pirola A, Donandoni C, Fontana D, Mezzatesta C, Magistroni V, Bianchi B, Borin L, Fumagalli M, Gambacorti-Passerini C.

Am J Hematol. 2015 Dec;90(12):E227-8. doi: 10.1002/ajh.24210. Epub 2015 Nov 17. No abstract available.

5.

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.

Sharma N, Magistroni V, Piazza R, Citterio S, Mezzatesta C, Khandelwal P, Pirola A, Gambacorti-Passerini C.

Mol Cancer. 2015 Jul 16;14:132. doi: 10.1186/s12943-015-0407-0.

6.

Age and dPCR can predict relapse in CML patients who discontinued imatinib: the ISAV study.

Mori S, Vagge E, le Coutre P, Abruzzese E, Martino B, Pungolino E, Elena C, Pierri I, Assouline S, D'Emilio A, Gozzini A, Giraldo P, Stagno F, Iurlo A, Luciani M, De Riso G, Redaelli S, Kim DW, Pirola A, Mezzatesta C, Petroccione A, Lodolo D'Oria A, Crivori P, Piazza R, Gambacorti-Passerini C.

Am J Hematol. 2015 Oct;90(10):910-4. doi: 10.1002/ajh.24120. Epub 2015 Sep 10.

7.

Decreased function of Fas in patients displaying delayed progression of HIV-induced immune deficiency.

Bottarel F, Bonissoni S, Lucia MB, Bragardo M, Bensi T, Buonfiglio D, Mezzatesta C, DiFranco D, Balotta C, Capobianchi MR, Dianzani I, Cauda R, Dianzani U.

Hematol J. 2001;2(4):220-7.

PMID:
11920253
8.

Proteasomes are a target of the anti-tumour drug vinblastine.

Piccinini M, Tazartes O, Mezzatesta C, Ricotti E, Bedino S, Grosso F, Dianzani U, Tovo PA, Mostert M, Musso A, Rinaudo MT.

Biochem J. 2001 Jun 15;356(Pt 3):835-41.

9.

The T cell activation molecule H4 and the CD28-like molecule ICOS are identical.

Buonfiglio D, Bragardo M, Redoglia V, Vaschetto R, Bottarel F, Bonissoni S, Bensi T, Mezzatesta C, Janeway CA Jr, Dianzani U.

Eur J Immunol. 2000 Dec;30(12):3463-7.

10.

Defective T cell fas function in patients with multiple sclerosis.

Comi C, Leone M, Bonissoni S, DeFranco S, Bottarel F, Mezzatesta C, Chiocchetti A, Perla F, Monaco F, Dianzani U.

Neurology. 2000 Oct 10;55(7):921-7.

PMID:
11061245
11.

Cloning and expression of rat CYP2E1 in Saccharomyces cerevisiae: detection of genotoxicity of N-alkylformamides.

Del Carratore MR, Mezzatesta C, Hidestrand M, Neve P, Amato G, Gervasi PG.

Environ Mol Mutagen. 2000;36(2):97-104.

PMID:
11013407

Supplemental Content

Loading ...
Support Center